Doctor profile · Federal record
Dr. Jorge Diaz, MD
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Internal Medicine Physician · Huntsville, AL
- NPI 1558517987
- Accepts Medicare
- MIPS 76.3 / 100 · 2023
- 22 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1 Hospital Dr Sw
Huntsville, AL 358016455
(256) 705-4224 - Mailing address
-
Po Box 18428
Huntsville, AL 358048428
Credentials & registration
- NPI registered
- August 2008 — 18 yrs on file
- Profile last updated
- January 27, 2023
- Year of graduation
- 2004 — 22 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Alabama #31152
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1558517987. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
130,653
Distinct HCPCS
10
Medicare allowed
$3,209,793
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0642 |
Injection, levoleucovorin (khapzory), 0.5 mg | 27,400 | 13 | $1 | |
J9271 |
Injection, pembrolizumab, 1 mg | 14,000 | 21 | $54 | |
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 12,690 | 26 | $3 | |
J9299 |
Injection, nivolumab, 1 mg | 11,160 | 11 | $30 | |
J0897 |
Injection, denosumab, 1 mg | 9,300 | 93 | $23 | |
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 9,000 | 13 | $47 | |
J0185 |
Injection, aprepitant, 1 mg | 6,630 | 17 | $2 | |
J1437 |
Injection, ferric derisomaltose, 10 mg | 6,100 | 55 | $21 | |
J1568 |
Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 4,838 | 25 | $40 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 3,184 | 99 | $0 |
In context: peer comparison
Among 6 peers in this city , average services per provider: 1,381. This provider delivers 95× the peer median.Open Payments
Industry payments received
All-time total
$2,670
Transactions
82
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| PFIZER INC. | 16 | $370.61 | |
| Amgen Inc. | 2 | $310.37 | |
| Novartis Pharmaceuticals Corporation | 14 | $289.62 | |
| BeiGene USA, Inc. | 5 | $231.49 | |
| Incyte Corporation | 3 | $166.10 | |
| AstraZeneca Pharmaceuticals LP | 7 | $146.29 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $125.31 | |
| Merck Sharp & Dohme LLC | 4 | $98.71 | |
| Gilead Sciences, Inc. | 5 | $98.53 | |
| Janssen Biotech, Inc. | 5 | $91.32 | |
| ABBVIE INC. | 5 | $88.77 | |
| Daiichi Sankyo Inc. | 3 | $73.49 | |
| E.R. Squibb & Sons, L.L.C. | 4 | $67.75 | |
| GENZYME CORPORATION | 2 | $49.10 | |
| Alexion Pharmaceuticals, Inc. | 2 | $48.16 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
900
Patients
273
Total drug cost
$1,318,944
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Eliquis (Apixaban) | Brand | 168 | 39 | $113,094 |
| Prednisone | Generic | 103 | 42 | $858 |
| Anastrozole | Generic | 84 | 29 | $2,919 |
| Levothyroxine Sodium | Generic | 67 | 23 | $463 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 60 | 26 | $1,342 |
| Revlimid (Lenalidomide) | Brand | 54 | 0 | $1,025,081 |
| Gabapentin | Generic | 51 | 17 | $576 |
| Letrozole | Generic | 46 | 16 | $2,923 |
| Hydroxyurea | Generic | 45 | 0 | $1,820 |
| Furosemide | Generic | 42 | 21 | $154 |
Hospital affiliations
Frequently asked questions
What is Dr. Jorge Diaz's medical specialty?
Dr. Jorge Diaz practices Hematology & Oncology Physician in Huntsville, AL.
Where does Dr. Jorge Diaz practice?
Dr. Jorge Diaz practices at 1 Hospital Dr Sw, Huntsville, AL 358016455. Office phone: 2567054224.
What is Dr. Jorge Diaz's NPI?
Dr. Jorge Diaz's National Provider Identifier (NPI) is 1558517987, issued by NPPES.
Does Dr. Jorge Diaz accept Medicare assignment?
Yes. Dr. Jorge Diaz accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Jorge Diaz commonly perform?
Top Medicare-reported procedures in 2023: Injection, levoleucovorin (khapzory), 0.5 mg (HCPCS J0642); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS J0881). Source: CMS Medicare Physician & Other Practitioners file.